These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
106 related items for PubMed ID: 24424134
21. Design, synthesis and biological evaluation of N,N-3-phenyl-3-benzylaminopropanamide derivatives as novel cholesteryl ester transfer protein inhibitor. Zhao D, Xie H, Bai C, Liu C, Hao C, Zhao S, Yuan H, Luo C, Wang J, Lin B, Zheng J, Cheng M. Bioorg Med Chem; 2016 Apr 15; 24(8):1589-97. PubMed ID: 27010500 [Abstract] [Full Text] [Related]
22. SAR studies on the central phenyl ring of substituted biphenyl oxazolidinone-potent CETP inhibitors. Lu Z, Chen YH, Napolitano JB, Taylor G, Ali A, Hammond ML, Deng Q, Tan E, Tong X, Xu SS, Latham MJ, Peterson LB, Anderson MS, Eveland SS, Guo Q, Hyland SA, Milot DP, Chen Y, Sparrow CP, Wright SD, Sinclair PJ. Bioorg Med Chem Lett; 2012 Jan 01; 22(1):199-203. PubMed ID: 22142541 [Abstract] [Full Text] [Related]
29. Carbonic anhydrase inhibitors. Synthesis of heterocyclic 4-substituted pyridine-3-sulfonamide derivatives and their inhibition of the human cytosolic isozymes I and II and transmembrane tumor-associated isozymes IX and XII. Sławiński J, Szafrański K, Vullo D, Supuran CT. Eur J Med Chem; 2013 Nov 01; 69():701-10. PubMed ID: 24095761 [Abstract] [Full Text] [Related]
31. Design, synthesis, and biological evaluation of 8-biarylquinolines: a novel class of PDE4 inhibitors. Gallant M, Chauret N, Claveau D, Day S, Deschênes D, Dubé D, Huang Z, Lacombe P, Laliberté F, Lévesque JF, Liu S, Macdonald D, Mancini J, Masson P, Mastracchio A, Nicholson D, Nicoll-Griffith DA, Perrier H, Salem M, Styhler A, Young RN, Girard Y. Bioorg Med Chem Lett; 2008 Feb 15; 18(4):1407-12. PubMed ID: 18207397 [Abstract] [Full Text] [Related]
33. Future of cholesteryl ester transfer protein inhibitors. Rader DJ, deGoma EM. Annu Rev Med; 2014 Feb 15; 65():385-403. PubMed ID: 24422575 [Abstract] [Full Text] [Related]
34. Chromanol derivatives--a novel class of CETP inhibitors. Vakalopoulos A, Schmeck C, Thutewohl M, Li V, Bischoff H, Lustig K, Weber O, Paulsen H, Elias H. Bioorg Med Chem Lett; 2011 Jan 01; 21(1):488-91. PubMed ID: 21084191 [Abstract] [Full Text] [Related]
35. Phase 0 study of the inhibition of cholesteryl ester transfer protein activity by JNJ-28545595 in plasma from normolipidemic and dyslipidemic humans. Sarich TC, Connelly MA, Schranz DB, Ghosh A, Manitpisitkul P, Leary ET, Rothenberg P, Demarest KT, Damiano BP. Int J Clin Pharmacol Ther; 2012 Aug 01; 50(8):584-94. PubMed ID: 22578199 [Abstract] [Full Text] [Related]